Cargando…
Scleroderma and interstitial lung disease - A case report
BACKGROUND: Systemic sclerosis with interstitial lung disease is one of the rarely reported autoimmune disorders. The ILD associated with systemic sclerosis is the most common cause of mortality in these patients. CASE PRESENTATION: A 37-year-old female patient who is a known case of Scleroderma, Co...
Autores principales: | Gul, Fahad, Siddiqui, Amna, Srikaram, Prakhyath, Fatima, Nabeela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283800/ https://www.ncbi.nlm.nih.gov/pubmed/35846852 http://dx.doi.org/10.1016/j.amsu.2022.104143 |
Ejemplares similares
-
Cotrimoxazole‐induced hyperkalemia in renal transplant patient—Case report
por: Srikaram, Prakhyath, et al.
Publicado: (2022) -
A transplant compatible with all patients: A salvage underway
por: Srikaram, Prakhyath, et al.
Publicado: (2022) -
Scleroderma-related interstitial lung disease
por: Suliman, Sally, et al.
Publicado: (2017) -
Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
por: Stock, Carmel J. W., et al.
Publicado: (2020) -
Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)